Navigation Links
CIRM Completes Briefing Visit to Stemedica Cell Technologies
Date:3/2/2009

Leadership of the California Institute for Regenerative Medicine ("CIRM") completed a two part visit to Stemedica Cell Technologies, Inc. ("Stemedica") to tour its manufacturing facility, R&D lab and corporate headquarters.

San Diego, Calif. (PRWEB) March 2, 2009 -- Leadership of the California Institute for Regenerative Medicine ("CIRM") completed a two part visit to Stemedica Cell Technologies, Inc. ("Stemedica") to tour its manufacturing facility, R&D lab and corporate headquarters.

"I was glad to have the opportunity to visit Stemedica and get to know more about its leadership, plans for the future and to see first hand the assets and potential they represent to the stem cell movement in California", said Dr. Alan Trounson, President of CIRM. "We want to have strong working relationships with all sectors of California's stem cell industry, including for-profit companies like Stemedica."

Prior to Dr. Trounson's visit, Dr. Marie Csete, CIRM's Chief Scientific Officer had the opportunity to visit Stemedica's manufacturing facility and R&D laboratory. "We're delighted to see Stemedica make the effort to secure a clinical grade manufacturing license from the State of California. We believe this capability will aid numerous organizations in California and around the world in their efforts to manufacture stem cell products for clinical application", said Dr. Csete.

"We were pleased to have Dr. Trounson and Dr. Marie Csete visit our facilities and receive a briefing from our leadership", said Dr. Maynard Howe, Stemedica's Vice Chairman & CEO. "We continue to play a pivotal role in the evolution of the stem cell industry in California and believe a supportive working relationship with CIRM is an essential part of this process.

Stuart Lipton, M.D., Ph.D., Sci
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Carrington Completes $8 Million Financing
5. Proteon Therapeutics Completes $12 Million Financing and Hires CFO
6. New Brunswick Scientific Completes Merger Transaction with Eppendorf
7. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
8. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
9. Optherion, Inc. Completes $37 Million Start Up Financing
10. Companys Partner Completes Trial Production of a New Antiviral Medicine
11. American Oriental Bioengineering Completes Acquisition of Guangxi Boke Pharmaceutical Company Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CIRM Completes Briefing Visit to Stemedica Cell Technologies
CIRM Completes Briefing Visit to Stemedica Cell Technologies
(Date:12/3/2009)...LADELPHIA, Dec. 3 Shire ...lty biopharmaceutical company, today announced a v...withdrawal of one lot of the Attention-Deficit/Hyp... Shire is taking this action because some Daytrana... their release liner removal specification, and as...
(Date:12/3/2009)...PKINTON, Mass., Dec. 3 C...ding provider of tools and services for drug disco...Living Image 4.0 software for IVIS® in vivo i...ore than 800 Caliper IVIS systems currently instal...atures advanced spectral unmixing tools to enhance...
(Date:12/2/2009)...A, Philippines, Dec. 2 Spectrum Bl... green energy companies on the planet. Through the... Planet,s President and Recycling Specialist Leroy...for over 25 years, stated that Spectrum Blue Steel...he stage for spectacular earnings because of the b...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Drug Discovery T...p; Opportunities ,, http://www.reportlinker.c...-Update-of-Market-Trends--Opportunities.html ,...g element of every pharmaceutical company,s busine...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... Carl Zeiss and Visage Imaging to Inte...Showcase Imaging and Visualization Software at Neu...ity, NJ (PRWEB) November 14, 2008 -- Norbert Haas,...ny,s Autostereoscopic 3D Displays will be showcase...n DC, November 15 -19th. Carl Zeiss, the world,s ...
...l-Based Hand Sanitizer May Minimize Viral Transmis...hanol-based hand sanitizer may significantly impac...multiple viruses, including norovirus, from food h...the University of Ottawa, Ontario, Canada, and Nor... findings in the August 2008 issue of the journal ...
.... 13 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS )...am &,Company, LLC,s Focus on Infectious Disease Co....m. EST (7:00 a.m. PST) at the Needham and Company...h.D., President and Chief Executive Officer of Ana...ee clinical programs: ANA598,and ANA773 in hepatit...
Other Biology Technology:TRIDELITY Display Solutions Partners With Two Of The World's Leading Imaging Software Companies 2TRIDELITY Display Solutions Partners With Two Of The World's Leading Imaging Software Companies 3Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference 2
(Date:12/4/2009)...ene activity in organs relevant for coronary arter... university Karolinska Institutet have identified ...tment of white blood cells into the atheroscleroti...in the open-access journal PLoS Genetics , sugges...s in the development of atherosclerosis may help t...
(Date:12/4/2009)...le in German . , A new study of the Max Planc...derstand the positive effect of dietary restrictio...ent organisms (fruit flies and mice) have shown th...th a potential negative side effect of diminished ... frequently with a reduced litter size on a low ca...
(Date:12/3/2009)...Dec. 3 BIO-key Internati... wireless public safety and finger-based biometric...ty of its shareholders at a Special Shareholder Me...s Law Enforcement Division to Interact911 Mobile S...n favor and 1.2% were opposed. ,, (Logo: http:...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Velos Inc Launches Velos On Demand for Velos eResearch Bringing Dynamically Scalable Economy to Customers 51176 1Velos Inc Launches Velos On Demand for Velos eResearch Bringing Dynamically Scalable Economy to Customers 51176 2Velos Inc Launches Velos On Demand for Velos eResearch Bringing Dynamically Scalable Economy to Customers 51176 3Scottsdale Healthcare Streamlines Contract Labor Process with Broadlane Workforce Management 51172 1Scottsdale Healthcare Streamlines Contract Labor Process with Broadlane Workforce Management 51172 2Scottsdale Healthcare Streamlines Contract Labor Process with Broadlane Workforce Management 51172 3Scottsdale Healthcare Streamlines Contract Labor Process with Broadlane Workforce Management 51172 4Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 1Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 2Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 3
...ennessee for the Ecological Society of America,s 9... state will be presenting the results of their res...ghts: , Past and present declines in Hemlocks and...Park Monday August 7, 5 ?6:30 PM, Exhibit Hall, Co...d (HWA) (Adelges tsugae) has brought about drastic...
...e that inhibits proliferation of a broad range of .... The findings, published in the May issue of Canc...bers are most likely to play a role in cancer prog...ccessful small molecule kinase inhibitors must dis...he complex signaling pathways involved in malignan...
... of Clinical and Applied Thrombosis/Hematosis show... insufficiency (CVI) in patients after supplementi...nt plant extract from the bark of the French marit...genol® demonstrate the antioxidant,s ability to im...lished results from this study showed Pycnogenol® ...
Other Biology News:Ecosystem services and invasive species 2Ecosystem services and invasive species 3Unique dual target specificity of kinase inhibitor key for success against cancer 2Study shows pine bark naturally decreases severe chronic venous insufficiency 2Study shows pine bark naturally decreases severe chronic venous insufficiency 3
EDG-1 Western blot control from Exalpha Biologicals, Inc.
TAKARA HYBRIDIZATION CHAMBER 1 from Takara Mirus Bio
Porcine IL-1 beta (IL-1F2) ELISpot Kit from R&D Systems
GIBCO Versene 1:5;000 (1X); liquid from Invitrogen
Biology Products: